Gw Pharma ADR (GWPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
218.96 -0.32 (-0.15%) 05/04/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 218.96 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 09-2018 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,128 | -9,019 | N/A | -295,167 | -170,459 |
| Depreciation Amortization | 12,757 | 9,240 | N/A | 9,290 | 7,054 |
| Income taxes - deferred | -2,654 | -9,698 | N/A | -317 | -3,770 |
| Accounts receivable | -22,104 | -44,623 | N/A | -804 | -277 |
| Other Working Capital | -39,157 | -60,653 | N/A | 17,541 | -8,112 |
| Other Operating Activity | 81,901 | -8,716 | 0 | 37,589 | 26,590 |
| Operating Cash Flow | $-27,385 | $-123,469 | $N/A | $-231,868 | $-148,974 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21,603 | -42,488 | N/A | -30,845 | -19,285 |
| Purchase Sale Intangibles | -6,404 | N/A | N/A | -2,042 | -812 |
| Other Investing Activity | -6,404 | 104,117 | 0 | -2,042 | -812 |
| Investing Cash Flow | $-28,007 | $61,629 | $N/A | $-32,887 | $-20,097 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -583 | -543 | N/A | -635 | -1,179 |
| Common Stock Issued | 1,579 | 2,878 | N/A | 298,552 | 122 |
| Other Financing Activity | -2,125 | -389 | 0 | -163 | -156 |
| Financing Cash Flow | $-1,129 | $1,946 | $N/A | $297,754 | $-1,213 |
| Exchange Rate Effect | 6,340 | 5,330 | N/A | -240 | 8,993 |
| Beginning Cash Position | 536,933 | 591,497 | N/A | 322,154 | 483,445 |
| End Cash Position | 486,752 | 536,933 | N/A | 354,913 | 322,154 |
| Net Cash Flow | $-50,181 | $-54,564 | $N/A | $32,759 | $-161,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,385 | -123,469 | N/A | -231,868 | -148,974 |
| Capital Expenditure | -21,603 | -42,488 | N/A | -31,362 | -19,285 |
| Free Cash Flow | -48,988 | -165,957 | 0 | -263,230 | -168,259 |